DELPHINE FOMBI-NDIFOR: Open Payments
NPI 1720798432 · BEAR, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 6 payments from 4 companies in 2025. Trend: 2023 $27 · 2024 $94 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $88 |
| Lundbeck LLC | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: REXULTI, ABILIFY ASIMTUFII, INGREZZA, AUSTEDO XR.
Industry payments across DE — which companies pay providers there.
